EPIX PHARMACEUTICALS EPIX (NASDAQ) $ 0.46 Change: +0.01 +2.17% | Volume: 64,450
Sponsored by Click here!

EPIX PHARMA INC - Fundamental Profile

Company Information

Ticker Symbol: EPIX
Exchange: NASD
Contact Info: 4 Maguire Road Lexington MA 02421 781-761-7600
CEO/President: Michael J. Astrue
Industry: Medical - Drugs / Standard Industry Code: 2834
Description: EPIX Pharmaceuticals, Inc., based in Cambridge, MA, discovers and develops innovative pharmaceuticals for imaging that are designed to transform the diagnosis, treatment and monitoring of disease. They use their proprietary Target Visualization Technology to create imaging pharmaceuticals targeted at the molecular level, enabling physicians to use Magnetic Resonance Imaging to obtain detailed information about specific disease processes. The Company\'s lead product, MS-325, is the first imaging pharmaceutical specifically designed for Magnetic Resonance Angiography.

Share Information

Shares Outstanding: 41,360 (000) Market Value: 18,640 ($000)
Percentage of Inst.Shareholders: 51.51% Number of Inst.Shareholders: 4.93%
Last Quarter Sales: 17.35 ($Mil.) Last Quarter Net Income: -2.34 ($Mil.)
Last Quarter EPS: -0.06 P/E Ratio: 0
Most Recent Earnings: -0.33 on 02/20/08 Earnings Per Share: -1.11
Most Recent Split: 10-15 on 08/17/06 Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

PFIZER INC -18.60 19.00
JOHNSON AND JOH +2.10 66.16
MERCK CO INC -40.70 31.78
BRISTOL MYERS S -26.10 20.43
SCHERING PLOUGH -45.30 16.44